EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Primary Immunodeficiency Diseases, Tumor Virus Infections, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease	Recruiting	Phase 2	2025-08-08		NCT03266653

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital of Philadelphia	215
Indiana University	297
Medical College of Wisconsin	201
Nationwide Children's Hospital	97
New York Medical College	28
University of California, Los Angeles	355
University of California, San Francisco	637
Washington University School of Medicine	475

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Pennsylvania	Philadelphia	United States	8
Children's Hosptial Los Angeles	Los Angeles	United States	1
Johns Hopkins	Baltimore	United States	39
Medical College of Wisconsin/Children's Hospital of Wisconsin	Milwaukee	United States	6
Nationwide Children's Hosptial	Columbus	United States	9
New York Medical College	Valhalla	United States	71
University of California San Francisco	San Francisco	United States	80
Washington University	St Louis	United States	34